schizandrin b has been researched along with cyclosporine in 3 studies
| Studies (schizandrin b) | Trials (schizandrin b) | Recent Studies (post-2010) (schizandrin b) | Studies (cyclosporine) | Trials (cyclosporine) | Recent Studies (post-2010) (cyclosporine) |
|---|---|---|---|---|---|
| 321 | 1 | 218 | 30,547 | 3,802 | 6,558 |
| 9 | 0 | 7 | 377 | 2 | 170 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Huang, M; Huang, Z; Jin, J; Qiu, Y; Wang, Y; Zhu, S | 1 |
| Lai, Q; Lai, S; Li, T; Luo, Z; Wang, Q; Wei, H; Wu, C; Yu, Y | 1 |
| Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
3 other study(ies) available for schizandrin b and cyclosporine
| Article | Year |
|---|---|
Protective effect of schisandrin B against cyclosporine A-induced nephrotoxicity in vitro and in vivo.
Topics: Adenosine Triphosphate; Animals; Antioxidants; Apoptosis; Blood Urea Nitrogen; Cell Survival; Creatinine; Cyclooctanes; Cyclosporine; Enzyme Inhibitors; Fruit; Glutathione; Humans; Kidney; Kidney Diseases; L-Lactate Dehydrogenase; Lignans; Male; Malondialdehyde; Mice; Mice, Inbred Strains; Oxidative Stress; Phytotherapy; Plant Extracts; Polycyclic Compounds; Reactive Oxygen Species; Schisandra | 2012 |
Attenuation of cyclosporine A induced nephrotoxicity by schisandrin B through suppression of oxidative stress, apoptosis and autophagy.
Topics: Acute Kidney Injury; Anti-Inflammatory Agents; Apoptosis; Autophagy; Cell Line; Cyclooctanes; Cyclosporine; Cytoprotection; Epithelial Cells; Glutamate-Cysteine Ligase; Heme Oxygenase-1; Humans; Kidney; Lignans; NAD(P)H Dehydrogenase (Quinone); NF-E2-Related Factor 2; Oxidative Stress; Polycyclic Compounds; Reactive Oxygen Species; Schisandra | 2017 |
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |